Allogeneic double‐negative T cell therapy for relapsed <scp>acute myeloid leukemia</scp> patients post <scp>allogeneic hematopoietic stem cell transplantation</scp>: A first‐in‐human phase I studyBaolin Tang, Xiaoyu Zhu, Wen Yao et al.|American Journal of Hematology|2022Cited by 26
Pharmacokinetics, Efficacy and Safety Evaluation of FRSW107 in Previously Treated Hemophilia a Patients: A Multicentre, Open-Label, Non-Randomized Phase III StudyFeng Xue, Renchi Yang, Hu Zhou et al.|Blood|2022Cited by 0